Dynomics aims to be the worldwide leader in the development of tests that provide diagnostic information on the classification of leukemia and lymphoma and information on the prognosis and staging of the disease. The developed tests present the clinician with a meaningful improvement over current methods for diagnosing leukemia and lymphoma.